John C. Reed

Insider Reports History

Entity
Individual
Location
One Johnson & Johnson Plaza, Whq 2134, New Brunswick, NJ
Signature
/s/ Laura McFalls, as attorney-in-fact for John C. Reed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John C. Reed:

Stock Role Class Num Shares Value Price $ Report Date Ownership
JOHNSON & JOHNSON EVP, Innovative Medicine, R&D Restricted Share Units 53.5K $8.68M $162.16 May 1, 2024 Direct
JOHNSON & JOHNSON EVP, Innovative Medicine, R&D Restricted Share Units 50.5K $8.34M $165.06 May 1, 2024 Direct
JOHNSON & JOHNSON EVP, Innovative Medicine, R&D Employee Stock Options (Right to Buy) 65.2K $5.89M $90.44 Feb 15, 2024 Direct
JOHNSON & JOHNSON EVP, Innovative Medicine, R&D Common Stock 14.6K $2.11M $144.59 May 1, 2024 Direct

Insider Reports Filed by John C. Reed

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JNJ JOHNSON & JOHNSON May 1, 2024 3 -$1.59M 4/A Oct 31, 2024 EVP, Innovative Medicine, R&D
JNJ JOHNSON & JOHNSON Feb 15, 2024 2 $0 4 Feb 20, 2024 EVP, Innovative Medicine, R&D
JNJ JOHNSON & JOHNSON May 1, 2023 1 $0 4 May 2, 2023 EVP, Pharmaceuticals R&D
JNJ JOHNSON & JOHNSON Apr 3, 2023 0 $0 3 Apr 13, 2023 EVP, Pharmaceuticals R&D